Pinnacle Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
|
|||||
|
2025
Q1 | $12.1M | Buy |
|
|||||
|
2024
Q4 | $5.19M | Buy |
|
|||||
|
2024
Q3 | $2.46M | Sell |
|
|||||
|
2024
Q2 | $5.09M | Buy |
|
|||||
|
2024
Q1 | $3.82M | Buy |
|
|||||
|
2023
Q4 | $2.46M | Buy |
|
|||||
|
2023
Q3 | $1.83M | Buy |
|
|||||
|
2023
Q2 | $1.31M | Buy |
|
|||||
|
2023
Q1 | $593K | Buy |
|
|||||
|
2022
Q4 | $428K | Sell |
|
|||||
|
2022
Q3 | $481K | Buy |
|
|||||
|
2022
Q2 | $424K | Buy |
|
|||||
|
2022
Q1 | $319K | Buy |
|
|||||
|
2021
Q4 | $264K | Sell |
|
|||||
|
2021
Q3 | $257K | Sell |
|
|||||
|
2021
Q2 | $326K | Buy |
|
|||||
|
2021
Q1 | $262K | Buy |
|
|||||
|
2020
Q4 | $241K | Buy |
|
|||||
|
2020
Q3 | $251K | Buy |
|
|||||
|
2020
Q2 | $267K | Sell |
|
|||||
|
2020
Q1 | $266K | Hold |
|
|||||
|
2019
Q4 | $245K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $202K | Hold |
|
|||||
|
2019
Q1 | $202K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $231K | Hold |
|
|||||
|
2018
Q2 | $204K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $277K | Sell |
|
|||||
|
2017
Q1 | $372K | Sell |
|
|||||
|
2016
Q4 | $273K | Buy |
|
|||||
|
2016
Q3 | $288K | Buy |
|
|||||
|
2016
Q2 | $224K | Hold |
|
|||||
|
2016
Q1 | $207K | Sell |
|
|||||
|
2015
Q4 | $507K | Sell |
|
|||||
|
2015
Q3 | $424K | Sell |
|
|||||
|
2015
Q2 | $512K | Hold |
|
|||||
|
2015
Q1 | $490K | Buy |
|
|||||
|
2014
Q4 | $457K | Sell |
|
|||||
|
2014
Q3 | $466K | Sell |
|
|||||
|
2014
Q2 | $421K | Sell |
|
|||||
|
2014
Q1 | $357K | Sell |
|
|||||
|
2013
Q4 | $1.3M | Sell |
|
|||||
|
2013
Q3 | $1.44M | Buy |
|
|||||
|
2013
Q2 | $1.46M | Buy |
|